PATENT CLAIM ANALYSIS

Application Number: 16213927
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["514", "690000"]

Abstract:
The present invention relates to methods of treating Leigh Syndrome and Leigh-like Syndrome with tocotrienol quinones, including alpha-tocotrienol quinone, in order to alleviate symptoms of the disease.

Claim (Index 21):
The composition of  claim 20 , wherein the composition is a pharmaceutical preparation, and wherein the alpha-tocotrienol quinone, alpha-tocotrienol hydroquinone, or mixture thereof, is present in a therapeutically effective amount.

Metadata:
- Claim Count in Document: 93.0
- Percentile: 98.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15178423', '13859592', '14233734', '15411861', '14850855']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8098293856137079
- 35 USC 102 Novelty (BERT): 0.5528605277741235
- Combined Prediction Score: 0.7841324998297495
- Mean Citation Score: 365.86111
- Max Citation Score: 473.4488
- Similarity Product: 270.1012499673843

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test